NO940245L - Quinolin eller quinazolinderivater, deres fremstilling og anvendelse - Google Patents

Quinolin eller quinazolinderivater, deres fremstilling og anvendelse

Info

Publication number
NO940245L
NO940245L NO940245A NO940245A NO940245L NO 940245 L NO940245 L NO 940245L NO 940245 A NO940245 A NO 940245A NO 940245 A NO940245 A NO 940245A NO 940245 L NO940245 L NO 940245L
Authority
NO
Norway
Prior art keywords
quinoline
preparation
quinazoline derivatives
integer
nitrogen
Prior art date
Application number
NO940245A
Other languages
English (en)
Other versions
NO306992B1 (no
Inventor
Takashi Sohda
Heruhiko Makino
Atsuo Baba
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of NO940245L publication Critical patent/NO940245L/no
Publication of NO306992B1 publication Critical patent/NO306992B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
NO940245A 1993-01-28 1994-01-24 Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene NO306992B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1262893 1993-01-28
JP20612893 1993-08-20

Publications (2)

Publication Number Publication Date
NO940245L true NO940245L (no) 1994-07-29
NO306992B1 NO306992B1 (no) 2000-01-24

Family

ID=26348258

Family Applications (2)

Application Number Title Priority Date Filing Date
NO940245A NO306992B1 (no) 1993-01-28 1994-01-24 Quinolinderivater, farmasoeytiske preparater inneholdende forbindelsene og anvendelsen av forbindelsene
NO940245D NO940245D0 (no) 1993-01-28 1994-01-24 Quinolin eller quinazolinderivater, deres fremstilling og anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO940245D NO940245D0 (no) 1993-01-28 1994-01-24 Quinolin eller quinazolinderivater, deres fremstilling og anvendelse

Country Status (15)

Country Link
US (3) US5436247A (no)
EP (1) EP0608870B1 (no)
KR (1) KR100224135B1 (no)
CN (1) CN1041520C (no)
AT (1) ATE205199T1 (no)
AU (1) AU673213B2 (no)
CA (1) CA2114300C (no)
DE (1) DE69428142T2 (no)
FI (1) FI940414A7 (no)
HU (1) HU217907B (no)
NO (2) NO306992B1 (no)
NZ (1) NZ250761A (no)
RU (1) RU2132330C1 (no)
SG (1) SG50546A1 (no)
TW (1) TW256832B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW232013B (no) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
ATE188377T1 (de) * 1993-06-29 2000-01-15 Takeda Chemical Industries Ltd Chinoline oder chinazolin-derivate und deren verwendung zur herstellung eines medikaments für die behandlung von osteoporose
AU1860995A (en) * 1994-03-08 1995-09-25 Takeda Chemical Industries Ltd. Quinoline or quinazoline derivatives as anti-inflammatory agents, in particular for treating arthritis
US5641788A (en) * 1994-06-07 1997-06-24 Takeda Chemical Industries, Ltd. Quinoline derivatives and pharmaceutical composition containing them
WO1996000223A1 (en) * 1994-06-24 1996-01-04 Takeda Chemical Industries, Ltd. Processes for production of quinoline or quinazoline derivatives and intermediates therefor
US5523312A (en) * 1994-09-27 1996-06-04 Sterling Winthrop Inc. Antipicornaviral agents
EP0830133A1 (en) * 1995-04-28 1998-03-25 Takeda Chemical Industries, Ltd. Therapeutic composition for arthritis
DE19610882A1 (de) * 1996-03-20 1997-09-25 Dresden Arzneimittel Neue 1,3,5-trisubstituierte Indazol-Derivate mit antiasthmatischer, antiallergischer, entzündungshemmender und immunmodulierender Wirkung, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
ES2235331T3 (es) * 1997-05-28 2005-07-01 Aventis Pharmaceuticals Inc Compuestos quinolina y quinoxalina que inhiben el factor de crecimiento derivado de plaquetas y/o tirosina quinasas p561ck.
DE19728835C1 (de) * 1997-07-05 1998-09-10 Ruetgers Vft Ag Verfahren zur Reinigung von Chinaldin
NZ520028A (en) * 2000-01-17 2004-07-30 Teijin Ltd Benzimidazole derivatives
WO2002051442A1 (en) * 2000-12-26 2002-07-04 Takeda Chemical Industries, Ltd. Concomitant drugs
RU2183116C1 (ru) * 2001-07-10 2002-06-10 Жаров Олег Владимирович Фармацевтическая композиция, обладающая болеутоляющим, противовоспалительным, антипиретическим и спазмолитическим действием
EP1539751B1 (en) * 2002-07-15 2008-05-07 Scinopharm Taiwan, Ltd. Process for the preparation of imidazo(1,2-a)pyridine-3-acetamides
AU2003277572A1 (en) * 2002-11-06 2004-06-07 Nissan Chemical Industries, Ltd. Process for producing quinolinecarbaldehyde
US20050009817A1 (en) * 2003-04-30 2005-01-13 Jennifer Savoy Substituted heteroaryls
US7937406B2 (en) * 2003-09-11 2011-05-03 Oracle America, Inc. Mechanism for automatically establishing a resource grid
CN101068788A (zh) * 2004-11-01 2007-11-07 弗·哈夫曼-拉罗切有限公司 作为gabab受体的别构增强剂的喹啉化合物
DE102004055633A1 (de) * 2004-11-12 2006-05-18 Schering Ag 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer
WO2007109274A2 (en) * 2006-03-21 2007-09-27 Alza Corporation Hydratable polymeric ester matrix for drug electrotransport
CA2781865A1 (en) 2009-06-25 2010-12-29 Amgen Inc. Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
WO2012068343A1 (en) * 2010-11-17 2012-05-24 Amgen Inc. Quinoline derivatives as pik3 inhibitors
ES2596243T3 (es) * 2012-08-24 2017-01-05 F. Hoffmann-La Roche Ag Nuevos derivados bicíclicos de piridina

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4438267A (en) * 1980-11-11 1984-03-20 Daluge Susan M Monoheteroring compounds and their use
GB8307865D0 (en) * 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5084462A (en) * 1988-04-26 1992-01-28 The Du Pont Merck Pharmaceutical Company 4-quinoline carboxylic acid derivatives useful as immunosuppressive agents
GB8827822D0 (en) * 1988-11-29 1988-12-29 Janssen Pharmaceutica Nv (1h-azol-1-ylmethyl)substituted quinoline derivatives
CA2002864C (en) * 1988-11-29 1999-11-16 Eddy J. E. Freyne (1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
TW232013B (no) * 1992-04-24 1994-10-11 Takeda Pharm Industry Co Ltd
KR100224135B1 (ko) * 1993-01-28 1999-10-15 다께다 구니오 퀴놀린 또는 퀴나졸린 유도체, 그 제조 및 용도
WO1996000223A1 (en) * 1994-06-24 1996-01-04 Takeda Chemical Industries, Ltd. Processes for production of quinoline or quinazoline derivatives and intermediates therefor

Also Published As

Publication number Publication date
DE69428142D1 (de) 2001-10-11
AU673213B2 (en) 1996-10-31
EP0608870A1 (en) 1994-08-03
FI940414L (fi) 1994-07-29
EP0608870B1 (en) 2001-09-05
DE69428142T2 (de) 2002-07-04
RU2132330C1 (ru) 1999-06-27
KR940018381A (ko) 1994-08-16
FI940414A7 (fi) 1994-07-29
HU217907B (hu) 2000-05-28
CA2114300A1 (en) 1994-07-29
AU5474294A (en) 1994-08-04
US5436247A (en) 1995-07-25
CA2114300C (en) 2000-10-17
CN1041520C (zh) 1999-01-06
TW256832B (no) 1995-09-11
HU9400250D0 (en) 1994-05-30
NZ250761A (en) 1995-03-28
NO940245D0 (no) 1994-01-24
KR100224135B1 (ko) 1999-10-15
ATE205199T1 (de) 2001-09-15
CN1105363A (zh) 1995-07-19
NO306992B1 (no) 2000-01-24
US5932592A (en) 1999-08-03
HUT70194A (en) 1995-09-28
SG50546A1 (en) 1998-07-20
FI940414A0 (fi) 1994-01-27
US5770602A (en) 1998-06-23

Similar Documents

Publication Publication Date Title
NO940245D0 (no) Quinolin eller quinazolinderivater, deres fremstilling og anvendelse
FI953968A0 (fi) Antraniiliset happojohdannaiset
NO900306D0 (no) Fremgangsmaate for fremstilling av nye pyrazolopyridin-forbindelser.
RU94002335A (ru) Производные хинолина или хиназолина и способ их получения
EA200100755A1 (ru) 4-оксо-1,4-дигидро-3-хинолинкарбоксамиды как антивирусные агенты
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
NO904377D0 (no) Tricykliske karbapenemforbindelser.
ATE147386T1 (de) Kondensierte pyrimidinderivate, ihre herstellung und ihre verwendung als antitumormittel
NO931482D0 (no) Farmasoeytiske sammensetninger inneholdende quinolin- og quinazolinderivater og nye forbindelser for disse
ATE110081T1 (de) Cephalosporinderivate mit in der lage 3 eine thioalkylthiogruppe.
AU5504694A (en) Substituted amic acid derivatives
AU577358B2 (en) Use of quinoline derivatives as herbicide antidotes
NO307883B1 (no) Antibakterielle pyridonkarboksylsyrederivater
DK291488A (da) Alkansulfonanilidderivater
DE69319939D1 (de) Aminobenzoesäure Derivate
ATE205209T1 (de) Chinolincarbonsäurederivate und ihre salze
GEP19960472B (en) Method of producing derivative of quinoline or its pharmaceutically acceptable ester, or their salts
ATE81502T1 (de) Acylsulfonamid-derivate von alphacarbocyclyltoluyls|uren und ihre verwendung als leukotrienantagonisten.